Kamal Adawi, M.S., MBA
Chief Financial Officer
Kamal Adawi is the Chief Financial Officer at Pathway Genomics. He previously held the position of Vice President of Finance. Prior to joining Pathway Genomics, Kamal served as the director of financial planning and analysis at Exagen Diagnostics, a commercial-stage diagnostics company focusing on testing for autoimmune rheumatic diseases. At Exagen, he established the finance department in San Diego to support the company’s transition from a private company in New Mexico to an IPO-ready company in San Diego. Kamal previously managed the finance departments for GenMark Dx and Digirad, both publicly traded diagnostic companies. He also served in various capacities in the finance and accounting departments at Becton, Dickinson and Co., a global medical technology company.
Kamal’s education includes three degrees in the field of business. He earned a bachelor’s degree from Michigan State University with a major in finance, an MBA from Oakland University with a focus on management and a master’s degree in finance from San Diego State University.